DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.

THE march of AI now seems unstoppable in every part of our lives, from choosing the TV we watch to making our trains run on ...

Researchers have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with ...

Artificial intelligence isn’t just about high-tech hospitals or luxury clinics—it’s changing how and where people get cancer ...

Southern Illinois Healthcare (SIH) has introduced a groundbreaking advancement in lung care for the region. SIH Memorial ...

The company recently reported that the four-protein test with algorithm-based analysis performed with 83.5 percent sensitivity and 90.3 percent specificity.

Priya Hays discusses the integration of AI into personalized medicine (PM), highlighting its potential to enhance healthcare ...

Imagine being armed with precautionary measures to fight a disease – like being vaccinated before the flu season arrives.

Mass General Brigham’s HPV-DeepSeek test enables much earlier cancer detection through a blood sample, creating a new ...

A magnetic microrobot navigates lung airways, drills microlesions, gathers biomarkers, and rapidly classifies cancer tissue ...

Pioneering liquid biopsy platform for early lung cancer detection strengthens IP and accelerates commercial strategy in China and Japan diagnostic markets. Vancouver, British Columbia--(Newsfile Corp.

The authors have declared no conflicts of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The work was supported ...